Genocea Biosciences (GNCA) Misses Q2 EPS by 2c

Genocea Biosciences (NASDAQ: GNCA) reported Q2 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• TD Cowen Reiterates Buy Rating on NVIDIA (NVDA), 'unlikely to move significantly on earnings'
• Taylor Devices (TAYD) Misses Q4 EPS by 31c